» Articles » PMID: 9775698

Depression in Parkinson's Disease. The Impact of Symptom Overlap on Prevalence

Overview
Journal Psychosomatics
Publisher Elsevier
Specialty Psychiatry
Date 1998 Oct 17
PMID 9775698
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The reported prevalence of depression concomitant with Parkinson's disease varies greatly in the literature, which may partly be explained by symptom overlap. To determine the impact of symptom overlap on the prevalence, the authors tested 100 Parkinson's disease patients for major depression (DSM-III-R) with both a standard, inclusive method and a diagnostic-etiologic, exclusive method. The authors found that the prevalence detected with the inclusive method (23%) decreased when the exclusive method was used (13%), which was mainly caused by lower scores on the item "loss of interest." The study's findings give empirical support for the relevance of the new category in DSM-IV "mood disorder due to a general medical condition."

Citing Articles

The Use of Melatoninergic Antidepressants for Stabilization of Remission in Depression Comorbid with Alcohol Abuse, Anxiety or Neuropsychiatric Disorders: A Systematic Review.

Klimanova S, Radionov D, Shova N, Kotsyubinskaya Y, Yarygina Y, Berezina A Consort Psychiatr. 2025; 5(4):40-62.

PMID: 39980619 PMC: 11839218. DOI: 10.17816/CP15560.


miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease.

Wan Z, Rasheed M, Li Y, Li Q, Wang P, Li J Mol Neurobiol. 2023; 60(10):5642-5654.

PMID: 37329382 DOI: 10.1007/s12035-023-03391-y.


Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management.

Stocchi F, Antonini A, Barone P, Bellelli G, Fagiolini A, Strambi L Neurol Sci. 2023; 44(9):3123-3131.

PMID: 37100925 PMC: 10415449. DOI: 10.1007/s10072-023-06740-w.


Drug Choices and Advancements for Managing Depression in Parkinson's Disease.

Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano G, Alborghetti M Curr Neuropharmacol. 2019; 18(4):277-287.

PMID: 31622207 PMC: 7327944. DOI: 10.2174/1570159X17666191016094857.


Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Santiago J, Bottero V, Potashkin J Front Aging Neurosci. 2017; 9:394.

PMID: 29255414 PMC: 5722846. DOI: 10.3389/fnagi.2017.00394.